U.S. Veterinary Orthopedic Medicine Market Size, Share & Trends Analysis Report By Product (Biologics, Viscosupplements, Pharmaceuticals), By Animal Type, By Application, By Route Of Administration, By End-use, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1 Methodology and Scope
                  1.1 Market Segmentation And Scope
                      1.1.1 Regional Scope
                      1.1.2 Estimates And Forecast Timeline
                  1.2 Research Methodology
                  1.3 Information Procurement
                      1.3.1 Purchased Database:
                      1.3.2 GVR’s Internal Database
                      1.3.3 Secondary Sources
                      1.3.4 Primary Research
                  1.4 Information/data Analysis
                      1.4.1 Information Analysis
                  1.5 Market Formulation & Visualization
                  1.6 Data Validation & Publishing
                  1.7 Model Details
                      1.7.1 Approach 1: Commodity Flow Analysis
                          1.7.1.1 Hybrid Market Estimation Model
                      1.7.2 Global Market: Cagr Calculation
                      1.7.3 Approach 2: Parent Market Analysis
                  1.8 List Of Secondary Sources
Chapter 2 Executive Summary
                  2.1 Market Snapshot
                  2.2 Segment Snapshot
                  2.3 Segment Snapshot
                  2.4 Competitive Landscape Snapshot
Chapter 3 U.S. Veterinary Orthopedic Medicine Market Industry Outlook
                  3.1 Market Lineage Outlook
                      3.1.1 Parent Market Outlook
                      3.1.2 Ancillary Market Analysis
                  3.2 U.S. Veterinary Orthopedic Medicine Market Dynamics
                  3.3 Market Driver Impact Analysis
                      3.3.1 Increasing Incidence Of Orthopedic Problems
                      3.3.2 Growing Uptake Of Pet Insurance
                      3.3.3 Increase In Canine & Equine Population
                      3.3.4 Advancements In Veterinary Orthopedic Medicine
                      3.3.5 Supportive Initiatives
                  3.4 Market Restraint Impact Analysis
                      3.4.1. High Cost Of Treatment
                  3.5 Market Opportunity Analysis
                  3.6 Market Challenge Analysis
                  3.7 U.S. Veterinary Orthopedic Medicine Market: Porter’s 5 Forces Analysis
                      3.7.1 Bargaining Power Of Buyers: High
                      3.7.2 Bargaining Power Of Suppliers: Moderate - Low
                      3.7.3 Threat Of New Entrants: High
                      3.7.4 Threat Of Substitutes: Low - Moderate
                      3.7.5 Competitive Rivalry: High
                  3.8 U.S. Veterinary Orthopedic Medicine Market: Pestel Analysis
                      3.8.1 Political
                      3.8.2 Economic
                      3.8.3 Social
                      3.8.4 Technological
                      3.8.5 Environmental
                      3.8.6 Legal
                  3.9 Pet Owner Demographics & Behavior Analysis
                  3.10 Impact Of Covid-19 Pandemic, Recession & Inflation
                  3.11 U.S. Estimated Pet Dog & Horse Population (Million), 2018 To 2030
                  3.12 Estimated Number Of Intra-articularly Injected Canine Joints, 2022
Chapter 4 Product Estimates & Trend Analysis, 2018 - 2030 (USD Million)
                  4.1 U.S. Veterinary Orthopedic Medicine Market By Product: Key Takeaways
                  4.2 Product Movement Analysis & Market Share, 2022 & 2030
                  4.3 U.S. Veterinary Orthopedic Medicine Market Estimates & Forecast, By Product (USD Million)
                      4.3.1 U.S. Veterinary Orthopedic Medicine Market Estimates & Forecasts, By Biologics (USD Million)
                      4.3.2 U.S. Veterinary Orthopedic Medicine Market Estimates & Forecasts, By Pharmaceuticals (USD Million)
                  4.4 Biologics
                      4.4.1 Biologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                      4.4.2 Stem Cells
                          4.4.2.1 Stem Cells Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                      4.4.3 Platelet-rich Plasma (Prp)
                          4.4.3.1 Platelet-rich Plasma (Prp) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                      4.4.4 Other Biologics
                          4.4.4.1 Other Biologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                  4.5 Viscosupplements
                      4.5.1 Viscosupplements Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                  4.6 Pharmaceuticals
                      4.6.1 Pharmaceuticals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                      4.6.2 Steroids
                          4.6.2.1 Steroids Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                      4.6.3 Nsaids
                          4.6.3.1 Nsaids Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                      4.6.4 Others
                          4.6.4.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 5 Application Estimates & Trend Analysis, 2018 - 2030 (USD Million)
                  5.1 U.S. Veterinary Orthopedic Medicine Market By Solutions: Key Takeaways
                  5.2 Application Movement Analysis & Market Share, 2022 & 2030
                  5.3 U.S. Veterinary Orthopedic Medicine Market Estimates & Forecast, By Application (USD Million)
                  5.4 Osteoarthritis (Oa)
                      5.4.1 Osteoarthritis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                      5.4.2 Degenerative Joint Disease
                          5.4.2.1 Degenerative Joint Disease Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                      5.4.3 Others
                          5.4.3.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 6 Route Of Administration Estimates & Trend Analysis, 2018 - 2030 (USD Million)
                  6.1 U.S. Veterinary Orthopedic Medicine Market By Route Of Administration: Key Takeaways
                  6.2 Route Of Administration Movement Analysis & Market Share, 2022 & 2030
                  6.3 U.S. Veterinary Orthopedic Medicine Market Estimates & Forecast, By Route Of Administration (USD Million)
                      6.3.1 U.S. Veterinary Orthopedic Medicine Market Estimates & Forecasts, By Injectable (USD Million)
                  6.4 Injectable
                      6.4.1 Injectable Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                      6.4.2 Intra-muscular
                      6.4.3 Intra-muscular Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                      6.4.4 Intra-articular
                      6.4.5 Intra-articular Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                      6.4.6 Others
                      6.4.7 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                  6.5 Oral
                      6.5.1 Oral Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                  6.6 Others
                      6.6.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7 Animal Type Estimates & Trend Analysis, 2018 - 2030 (USD Million)
                  7.1 U.S. Veterinary Orthopedic Medicine Market, By Animal Type: Key Takeaways
                  7.2 Dogs Movement Analysis & Market Share, 2022 & 2030
                  7.3 U.S. Veterinary Orthopedic Medicine Market Estimates & Forecasts, By Animal Type (USD Million)
                      7.3.1 U.S. Veterinary Orthopedic Medicine Market Estimates & Forecasts, By Dogs (USD Million)
                  7.4 Dogs
                      7.4.1 Dogs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                      7.4.2 Small Breeds
                          7.4.2.1 Small Breeds Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                      7.4.3 Medium-sized Breeds
                          7.4.3.1 Medium-sized Breeds Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                      7.4.4 Large Breeds
                          7.4.4.1 Large Breeds Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                  7.5 Horses
                      7.5.1 Horses Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8 End-use Estimates & Trend Analysis, 2018 - 2030 (USD Million)
                  8.1 U.S. Veterinary Orthopedic Medicine Market By End-use: Key Takeaways
                  8.2 End-use Movement Analysis & Market Share, 2022 & 2030
                  8.3 U.S. Veterinary Orthopedic Medicine Market Estimates & Forecasts By End-use (USD Million)
                  8.4 Veterinary Hospitals & Clinics
                      8.4.1 Veterinary Hospitals & Clinics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                  8.5 At-home
                      8.5.1 At-home Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                  8.6 Others
                      8.6.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
                    9.1. Market Participant Categorization
                    9.2. Company Market Position Analysis/ Heap Map Analysis
                    9.3. Strategy Mapping
                        9.3.1. Mergers & Acquisitions
                        9.3.2. Partnerships & Collaborations
                        9.3.3. Others
                    9.4. Company Profiles
                        9.4.1. Zoetis
                            9.4.1.1. Participant’s Overview
                            9.4.1.2. Financial Performance
                            9.4.1.3. Product Benchmarking
                            9.4.1.4. Strategic Initiatives
                        9.4.2. Ardent Animal Health, LLC
                            9.4.2.1. Participant’s Overview
                            9.4.2.2. Financial Performance
                            9.4.2.3. Product Benchmarking
                            9.4.2.4. Strategic Initiatives
                        9.4.3. Enso Discoveries
                            9.4.3.1. Participant’s Overview
                            9.4.3.2. Financial Performance
                            9.4.3.3. Product Benchmarking
                            9.4.3.4. Strategic Initiatives
                        9.4.4. Arthrex, Inc.
                            9.4.4.1. Participant’s Overview
                            9.4.4.2. Financial Performance
                            9.4.4.3. Product Benchmarking
                            9.4.4.4. Strategic Initiatives
                        9.4.5. VetStem, Inc.
                            9.4.5.1. Participant’s Overview
                            9.4.5.2. Financial Performance
                            9.4.5.3. Product Benchmarking
                            9.4.5.4. Strategic Initiatives
                        9.4.6. Contura Vet US
                            9.4.6.1. Participant’s Overview
                            9.4.6.2. Financial Performance
                            9.4.6.3. Product Benchmarking
                            9.4.6.4. Strategic Initiatives
                        9.4.7. MEDREGO LLC
                            9.4.7.1. Participant’s Overview
                            9.4.7.2. Financial Performance
                            9.4.7.3. Product Benchmarking
                            9.4.7.4. Strategic Initiatives
                        9.4.8. PetVivo Holdings, Inc. (Spryng)
                            9.4.8.1. Participant’s Overview
                            9.4.8.2. Financial Performance
                            9.4.8.3. Product Benchmarking
                            9.4.8.4. Strategic Initiatives
                        9.4.9. T-Cyte Therepeutics
                            9.4.9.1. Participant’s Overview
                            9.4.9.2. Financial Performance
                            9.4.9.3. Product Benchmarking
                            9.4.9.4. Strategic Initiatives
                        9.4.10. Boehringer Ingelheim Animal Health USA Inc.
                            9.4.10.1. Participant’s Overview
                            9.4.10.2. Financial Performance
                            9.4.10.3. Product Benchmarking
                            9.4.10.4. Strategic Initiatives
                        9.4.11. American Regent, Inc.
                            9.4.11.1. Participant’s Overview
                            9.4.11.2. Financial Performance
                            9.4.11.3. Product Benchmarking
                            9.4.11.4. Strategic Initiatives
                        9.4.12. Bimeda U.S.
                            9.4.12.1. Participant’s Overview
                            9.4.12.2. Financial Performance
                            9.4.12.3. Product Benchmarking
                            9.4.12.4. Strategic Initiatives
                        9.4.13. Nucleus ProVets
                            9.4.13.1. Participant’s Overview
                            9.4.13.2. Financial Performance
                            9.4.13.3. Product Benchmarking
                            9.4.13.4. Strategic Initiatives
Chapter 10. Key Takeaways

List of Tables

Table 1 List of secondary sources
Table 2 Impact of COVID-19, recession, & inflation on some key players
Table 3 U.S. veterinary orthopedic medicine market estimates and forecast, by product, 2018 - 2030 (USD million)
Table 4 U.S. veterinary orthopedic medicine market estimates and forecast, by Biologics, 2018 - 2030 (USD million)
Table 5 U.S. veterinary orthopedic medicine market estimates and forecast, by Pharmaceuticals, 2018 - 2030 (USD million)
Table 6 U.S. veterinary orthopedic medicine market estimates and forecast, by application, 2018 - 2030 (USD million)
Table 7 U.S. veterinary orthopedic medicine market estimates and forecast, by route of administration, 2018 - 2030 (USD million)
Table 8 U.S. veterinary orthopedic medicine market estimates and forecast, by injectable, 2018 - 2030 (USD million)
Table 9 U.S. veterinary orthopedic medicine market estimates and forecast, by animal type, 2018 - 2030 (USD million)
Table 10 U.S. veterinary orthopedic medicine market estimates and forecast, by dogs, 2018 - 2030 (USD million)
Table 11 U.S. veterinary orthopedic medicine market estimates and forecast, by end-use, 2018 - 2030 (USD million)
Table 12 Participants' overview
Table 13 Financial performance
Table 14 Products benchmarking
Table 15 Key companies undertaking acquisitions.
Table 16 Key companies launching new products.
Table 17 Key companies undertaking partnership & collaboration strategies.
Table 18 Key market players initiating expansion.

List of Figures

Fig. 1 U.S. Veterinary Orthopedic Medicine Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Data Analysis Models
Fig. 6 Market Formulation and Validation
Fig. 7 Data Validating & Publishing
Fig. 8 General methodology for commodity flow analysis of animal health market
Fig. 9 Commodity flow analysis
Fig. 10 Parent market analysis
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Segment snapshot
Fig. 14 Competitive landscape snapshot
Fig. 15 Parent Market Analysis, 2023 (USD million)
Fig. 16 Ancillary market outlook, 2023
Fig. 17 U.S. Veterinary Orthopedic Medicine Market Dynamics
Fig. 18 U.S. Veterinary Orthopedic Medicine Market: PORTER’s analysis
Fig. 19 U.S. Veterinary Orthopedic Medicine Market: PESTEL analysis
Fig. 20 U.S. Veterinary Orthopedic Medicine Market by product: Key takeaways
Fig. 21 U.S. Veterinary Orthopedic Medicine Market by Product, Market share, 2023 & 2030
Fig. 22 Biologics market, 2018 - 2030 (USD million)
Fig. 23 Stem cells market, 2018 - 2030 (USD million)
Fig. 24 PRP market, 2018 - 2030 (USD million)
Fig. 25 Other biologics market, 2018 - 2030 (USD million)
Fig. 26 Viscosupplements market, 2018 - 2030 (USD million)
Fig. 27 Pharmaceuticals market, 2018 - 2030 (USD million)
Fig. 28 Steroids market, 2018 - 2030 (USD million)
Fig. 29 NSAIDS market, 2018 - 2030 (USD million)
Fig. 30 Others market, 2018 - 2030 (USD million)
Fig. 31 U.S. veterinary orthopedic medicine market by application: Key Takeaways
Fig. 32 U.S. veterinary orthopedic medicine market by application, market share, 2023 & 2030
Fig. 33 Osteoarthritis market, 2018 - 2030 (USD million)
Fig. 34 Degenerative joint disease market, 2018 - 2030 (USD million)
Fig. 35 Platelet-Rich Plasma (PRP) market, 2018 - 2030 (USD million)
Fig. 36 U.S. veterinary orthopedic medicine market by route of administration: Key Takeaways
Fig. 37 U.S. veterinary orthopedic medicine market by route of administration, market share, 2023 & 2030
Fig. 38 Injectable market, 2018 - 2030 (USD million)
Fig. 39 Intra-Muscular market, 2018 - 2030 (USD million)
Fig. 40 Intra-Articular market, 2018 - 2030 (USD million)
Fig. 41 Others market, 2018 - 2030 (USD million)
Fig. 42 Oral market, 2018 - 2030 (USD million)
Fig. 43 Others market, 2018 - 2030 (USD million)
Fig. 44 U.S. veterinary orthopedic medicine market, by animal type: Key takeaways
Fig. 45 U.S. veterinary orthopedic medicine market, by animal type: Market share, 2023 & 2030
Fig. 46 Dogs market, 2018 - 2030 (USD million)
Fig. 47 Small breeds market, 2018 - 2030 (USD million)
Fig. 48 Medium-sized breeds market, 2018 - 2030 (USD million)
Fig. 49 Large breeds market, 2018 - 2030 (USD million)
Fig. 50 Horses market, 2018 - 2030 (USD million)
Fig. 51 U.S. veterinary orthopedic medicine market, by end-use: Key takeaways
Fig. 52 U.S. veterinary orthopedic medicine market, by end-use, market share, 2023 & 2030
Fig. 53 Veterinary hospitals & clinics market, 2018 - 2030 (USD million)
Fig. 54 At-home market, 2018 - 2030 (USD million)
Fig. 55 Others market, 2018 - 2030 (USD million)
Fig. 56 Market Participant categorization
Fig. 57 Strategic Framework